GCM
IDXX icon

Graham Capital Management’s Idexx Laboratories IDXX Stock Holding History

Graham Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$463K Sell
879
-292
-25% -$164K 0.01% 737
2026
Q1 		$658K Buy
+1,171
New +$751K 0.02% 553
2024
Q3 		– Sell
-3,321
Closed -$1.62M – 1202
2024
Q2 		$1.62M Sell
3,321
-2,527
-43% -$1.27M 0.04% 290
2024
Q1 		$3.16M Buy
5,848
+4,742
+429% +$2.59M 0.06% 175
2023
Q4 		$614K Buy
+1,106
New +$519K 0.01% 534
2023
Q3 		– Sell
-18,125
Closed -$9.1M – 1145
2023
Q2 		$9.1M Buy
18,125
+17,395
+2,383% +$8.34M 0.26% 68
2023
Q1 		$365K Sell
730
-1,435
-66% -$687K 0.01% 828
2022
Q4 		$883K Buy
+2,165
New +$840K 0.03% 577

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Graham Capital Management's IDXX Position: Q2 2026 in Review

Graham Capital Management reduced its Idexx Laboratories (IDXX) stake by 25% in Q2 2026, selling an estimated $164K and leaving 879 shares worth $463K. The position accounts for 0.01% of the portfolio, ranked #737.

Graham Capital Management first reported a position in IDXX in Q4 2022 and has held it in 8 quarters since. The position peaked at $9.1M in Q2 2023. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Graham Capital Management held 879 shares of Idexx Laboratories worth $463K as of Q2 2026.
  • Graham Capital Management sold 292 Idexx Laboratories shares in Q2 2026, an estimated $164K.
  • Idexx Laboratories made up 0.01% of Graham Capital Management's portfolio in Q2 2026, its #737 holding.
  • Graham Capital Management first reported a position in Idexx Laboratories in Q4 2022 and has held it in 8 quarters since.
  • Graham Capital Management's Idexx Laboratories position peaked at $9.1M in Q2 2023.
  • 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.